Pivotal Therapeutics Inc.
PVTTF
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | 14.63% | 12.63% | 30.97% | -6.14% | -1.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.63% | 12.63% | 30.97% | -6.14% | -1.20% |
| Cost of Revenue | -3.18% | -6.86% | -9.72% | -6.62% | 187.28% |
| Gross Profit | 53.01% | 49.73% | 108.63% | 8.36% | -166.79% |
| SG&A Expenses | -47.95% | -34.89% | 29.85% | 80.29% | 50.97% |
| Depreciation & Amortization | 19.07% | 37.60% | 59.69% | 71.17% | 85.98% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -43.72% | -25.79% | 32.50% | 76.74% | 61.12% |
| Operating Income | 46.68% | 27.90% | -32.63% | -85.47% | -66.43% |
| Income Before Tax | 50.47% | 25.99% | -23.07% | -69.44% | -92.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 50.21% | 25.51% | -24.15% | -71.29% | -91.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.21% | 25.51% | -24.15% | -71.29% | -91.71% |
| EBIT | 46.68% | 27.90% | -32.63% | -85.47% | -66.43% |
| EBITDA | 47.88% | 29.03% | -32.10% | -85.75% | -66.11% |
| EPS Basic | 51.64% | 27.80% | -17.40% | -54.18% | -65.54% |
| Normalized Basic EPS | 51.99% | 28.19% | -16.34% | -53.67% | -67.50% |
| EPS Diluted | 51.64% | 27.80% | -17.40% | -54.18% | -65.54% |
| Normalized Diluted EPS | 51.99% | 28.19% | -16.34% | -53.67% | -67.50% |
| Average Basic Shares Outstanding | 2.49% | 5.20% | 8.12% | 11.66% | 15.63% |
| Average Diluted Shares Outstanding | 2.49% | 5.20% | 8.12% | 11.66% | 15.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |